You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

Details for Patent: 9,511,193

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,511,193

Title:	Assembly and indicator for a drug delivery device
Abstract:	An assembly for a drug delivery device, comprising a housing having a proximal end and a distal end, a piston rod and an indicator. The piston rod is adapted to be displaced distally with respect to the housing away from a proximal start position and towards a distal end position for delivering a drug. The indicator is adapted for indicating at least two different operation conditions of the assembly, the indicator being movable with respect to the housing from a first indication position for a first condition of the assembly into a second indication position for a second condition of the assembly. The piston rod and the indicator are configured to mechanically interact for converting movement of the piston rod into movement of the indicator. A first detent is provided which is configured to releasably secure the indicator in the first indication position such that movement into the second indication position is allowed. A second detent is provided which is configured to secure the indicator in the second indication position such that movement into the first indication position is prevented.
Inventor(s):	Plumptre; David (Droitwich Spa, GB), Terry; Warren (Leaminston Spa, GB), Veasey; Robert (Leamington Spa, GB), Jones; Matthew (Warwick, GB), Claughton; Timothy Giles (Congleton, GB)
Assignee:	SANOFI-AVENTIS DEUTSCHLAND GMBH (Frankfurt am Main, DE)
Application Number:	13/392,882
Patent Claim Types: see list of patent claims	Use; Delivery; Device;

Drugs Protected by US Patent 9,511,193

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,511,193

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	09171134	Sep 23, 2009

PCT Information
PCT Filed	September 21, 2010	PCT Application Number:	PCT/EP2010/063842
PCT Publication Date:	March 31, 2011	PCT Publication Number:	WO2011/036134

International Family Members for US Patent 9,511,193

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2010299934	⤷ Try a Trial
Brazil	112012006516	⤷ Try a Trial
Canada	2772686	⤷ Try a Trial
China	102510761	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.